Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors

A legfontosabb adatok

Ki végzi
Universidad Autonoma de Baja California
Hol
Mexikó1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
300 fő, tervezett
Kezdés
2024. okt. 1.
Várható befejezés
2026. dec. 31.
A vizsgálat típusa
Megfigyeléses, 5 csoport
A vizsgált kezelések
  • Exercise
  • Bioelectrical Impedance
  • Micronucleus Assay
  • Physical activity and sedentary time
  • Sleep
  • blood sampling
  • psychometrics
  • Nutritional Supplement
  • Genotyping
A regiszteradat frissítve
2025. március 11.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults in five groups: healthy young adults, athletes, older adults, university students and people with metabolic syndrome. It studies how insomnia affects body, fitness, metabolism and DNA.

Életkor
18 to 75 years. Healthy adults, athletes, students and people with metabolic syndrome: 18-35 years. Older adults: 65-75 years.
Nem
Men and women can join.
A betegség stádiuma
Healthy group: waist <90 cm (35 in) (men), <80 cm (31 in) (women), fasting glucose 70-110 mg/dL (3,9–6,1 mmol/L), blood pressure <120/80 mmHg, triglycerides <150 mg/dL (1,7 mmol/L), HDL-C >40 mg/dL (1 mmol/L) (men), >50 mg/dL (1,3 mmol/L) (women), activity 600-1500 MET-min/week. Athletes: structured sports training, activity >1500 MET-min/week. Older adults: no cognitive or mental health disorders. Metabolic syndrome group: waist >90 cm (35 in) (men), >80 cm (31 in) (women), fasting glucose >110 mg/dL (6,1 mmol/L), blood pressure >130/80 mmHg, triglycerides >150 mg/dL (1,7 mmol/L), HDL-C <40 mg/dL (1 mmol/L) (men), <50 mg/dL (1,3 mmol/L) (women), activity <600 MET-min/week.

A részvétel fő kizáró okai

  • Lung or breathing diseases that prevent exercise
  • Muscle, bone or joint injuries that prevent exercise
  • Rotating or night-shift work
  • Women with polycystic ovary syndrome (PCOS)
  • Women with high testosterone and a history of rare or light periods (oligomenorrhea)

A regiszter feltételei, szó szerint

Mind a 9 feltétel megnézéseKevesebb

Ki vehet részt

  • Each population group will meet the following inclusion criteria:
  • Healthy Individuals (18-35 years old, men and women); Waist circumference: <90 cm (men), <80 cm (women); Fasting glucose: 70-110 mg/dL; Blood pressure: <120/80 mmHg; Triglycerides: <150 mg/dL; HDL-C: >40 mg/dL (men), >50 mg/dL (women); Physical activity level: 600-1500 MET-min/week
  • Athletes (18-35 years old, men and women); *Engaged in structured sports training with a physical activity level >1500 MET-min/week
  • Older Adults (65-75 years old, men and women); *Free of cognitive or mental health disorders. No specific cardiometabolic or body composition criteria due to the study's exploratory nature
  • University Students (18-35 years old, men and women); *No specific cardiometabolic or body composition criteria due to the study's exploratory nature
  • Individuals with Metabolic Syndrome (18-35 years old, men and women); Waist circumference: >90 cm (men), >80 cm (women); Fasting glucose: >110 mg/dL; Blood pressure: >130/80 mmHg; Triglycerides: >150 mg/dL; HDL-C: <40 mg/dL (men), <50 mg/dL (women); Physical activity level: <600 MET-min/week

Ki nem vehet részt

  • Individuals with respiratory diseases or musculoskeletal injuries that prevent exercise, as determined by a clinical history review, a physical activity readiness questionnaire (PART-Q+), and pulmonary function tests (spirometry); Individuals with rotating or night-shift work schedules (e.g., emergency personnel, security guards), as circadian rhythm disruptions significantly impact sleep quality
  • Women diagnosed with polycystic ovary syndrome (PCOS) or showing high testosterone levels with a history of oligomenorrhea, as these conditions may influence metabolic and hormonal markers. However, women with menstrual irregularities related to premenstrual syndrome (PMS) or dysmenorrhea will not be excluded, given the established link between sleep disorders and menstrual cycle variations
  • This study does not involve chronic dietary or exercise interventions, nor does it require long-term participant follow-up, so no additional exclusion criteria apply

Nézd meg, megfelelhetsz-e

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 75 év között vagy?

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Insomnia is a highly prevalent sleep disorder worldwide, with an increasing incidence in athletes, older adults, university students, and individuals with metabolic syndrome. This disorder has been associated with metabolic dysfunction, cardiovascular diseases, and genetic instability. Recent evidence suggests that insomnia negatively impacts cardiorespiratory fitness, insulin sensitivity, and overall health through mechanisms involving neuroendocrine dysregulation, oxidative stress, and alterations in energy metabolism. However, the specific biological and environmental factors that contribute to its prevalence and health consequences remain poorly understood, particularly across different populations. Understanding these associations is crucial for developing effective prevention and intervention strategies to mitigate the long-term impact of insomnia. Therefore, this study aims to analyze the impact of insomnia on body composition, cardiorespiratory fitness, metabolic flexibility, and DNA integrity, across populations with high prevalence of insomnia, including athletes, older adults, university students, and individuals with metabolic syndrome. This study will also investigate which biological and lifestyle behaviors contribute to insomnia and its health consequences. By doing so, this work will provide critical insights into the physiological and molecular mechanisms that link insomnia with metabolic and cardiovascular dysfunction, contributing to the development of targeted interventions for at-risk populations

A vizsgálat 5 csoportja

  • Healthy young adults

    This group consists of individuals aged 18-35 with no prior diagnosis of insomnia, sleep disorders, or chronic metabolic conditions. Body composition, cardiorespiratory fitness, lifestyle behaviors, DNA integrity and metabolic flexibility will be examined in all participants.

    Kezelés: Exercise, Bioelectrical Impedance, Micronucleus Assay, Physical activity and sedentary time, Sleep, blood sampling, psychometrics, Nutritional Supplement és Genotyping

  • College Students

    University students aged 18-35 years, with current affiliation to the Universidad Autonoma de Baja California. Body composition, cardiorespiratory fitness, lifestyle behaviors, DNA integrity and metabolic flexibility will be examined in all participants.

    Kezelés: Exercise, Bioelectrical Impedance, Micronucleus Assay, Physical activity and sedentary time, Sleep, psychometrics, Nutritional Supplement és Genotyping

  • Athletes

    Amateur and professional athletes with 2 years of training and competitive experience. Body composition, cardiorespiratory fitness, lifestyle behaviors, DNA integrity and metabolic flexibility will be examined in all participants.

    Kezelés: Exercise, Bioelectrical Impedance, Micronucleus Assay, Physical activity and sedentary time, Sleep, blood sampling, psychometrics, Nutritional Supplement és Genotyping

  • Elders

    Older adults (65-75 years) without a medical history of cognitive disorders or mental health issues. Body composition, cardiorespiratory fitness, lifestyle behaviors, DNA integrity and metabolic flexibility will be examined in all participants.

    Kezelés: Exercise, Bioelectrical Impedance, Micronucleus Assay, Physical activity and sedentary time, Sleep, blood sampling, psychometrics, Nutritional Supplement és Genotyping

  • Metabolic syndrome

    Individuals aged 18-35 with previous diagnosis of metabolic syndrome. Body composition, cardiorespiratory fitness, lifestyle behaviors, DNA integrity and metabolic flexibility will be examined in all participants.

    Kezelés: Exercise, Bioelectrical Impedance, Micronucleus Assay, Physical activity and sedentary time, Sleep, blood sampling, psychometrics, Nutritional Supplement és Genotyping

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors: A Case-control Study
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Illeszkedési kérdések
Forrás: NCT06869486: ki vehet részt
A regiszteradat frissítve
2025. március 11.